The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.
Open accessAbstract
Apolipoprotein E (apo E) plays an important role in receptor mediated clearance of lipoprotein particles from plasma. Common genetic variation in apo E exists with three alleles coding for proteins called E2, E3, and E4. In in vitro receptor binding assays, E2 binds poorly, whereas E3 and E4 function normally. Recently, the apo E phenotype has been shown to have an effect on low density lipoprotein (LDL) cholesterol levels with levels in subjects with E2 lower and E4 higher than E3. We have examined the effect of the apo E polymorphism on dietary fat clearance using the vitamin A-fat loading test, which specifically labels intestinally derived lipoproteins with retinyl palmitate (RP). 27 normal subjects were studied, 10 with E3/3, 9 with E3/2, 7 with E4/3, and 1 with E4/4. After a vitamin A-containing fatty meal, postprandial RP concentrations were measured in chylomicron (Sf greater than 1,000) and nonchylomicron (Sf less than 1,000) fractions for 14 h. Compared with E3/3 subjects, E3/2 subjects had a significantly higher nonchylomicron RP concentration (P less than 0.05) (peak heights and areas below the curves) indicating slower clearance and the E4/3, E4/4 group had a significantly lower nonchylomicron RP concentration (P less than 0.05) indicating faster clearance. The clearance in the latter group was twice that of E3/2 subjects (P less than 0.01). Thus, heterozygosity for the defective form of apo E, E2, delays, and the surprising presence of a functionally normal allele, E4, increases clearance. This apo E effect on exogenous fat clearance may explain the recently described effect of the apo E phenotypes on LDL cholesterol levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,159
Castelli, W. P., Doyle, J. T., Gordon, T., Hames, C. G., Hjortland, M. C., Hulley, S. B., Kagan, A., & Zukel, W. J. (1977) · Circulation · doi:10.1161/01.cir.55.5.767 · Cited by 1,492
Lipoprotein receptors and cholesterol homeostasis
Mahley, R. W., & Innerarity, T. L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90001-1 · Cited by 755
Human apolipoprotein E. The complete amino acid sequence
Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34702-1 · Cited by 741
(1985) · PubMed · Cited by 706
Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34954-8 · Cited by 673
Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
UTERMANN, G., HEES, M., & STEINMETZ, A. (1977) · Nature · doi:10.1038/269604a0 · Cited by 666
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Self-citationKrauss, R. M., Levy, R. I., & Fredrickson, D. S. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107855 · Cited by 437
Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes
Zannis, V. I., Breslow, J. L., Utermann, G., Mahley, R. W., Weisgraber, K. H., Havel, R. J., Goldstein, J. L., Brown, M. S., Schonfeld, G., Hazzard, W. R., et al. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38094-9 · Cited by 436
Self-citationSherrill, B. C., Innerarity, T. L., & Mahley, R. W. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85951-3 · Cited by 426
Polymorphism of apolipoprotein E: Genetics of hyperlipoproteinemia type III
Utermann, G., Vogelberg, K. H., Steinmetz, A., Schoenborn, W., Pruin, N., Jaeschke, M., Hees, M., & Canzler, H. (1979) · Clinical Genetics · doi:10.1111/j.1399-0004.1979.tb02027.x · Cited by 405
Ehnholm, C., Lukka, M., Kuusi, T., Nikkilä, E., & Utermann, G. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38833-7 · Cited by 405
Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.
Hui, D. Y., Innerarity, T. L., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69254-9 · Cited by 383
Mahley, R. W., Hui, D. Y., Innerarity, T. L., & Weisgraber, K. H. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110365 · Cited by 375
Windler, E., Chao, Y., & Havel, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70647-4 · Cited by 365
Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat.
Shelburne, F., Hanks, J., Meyers, W., & Quarfordt, S. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109710 · Cited by 358
Abnormal in vivo metabolism of apolipoprotein E4 in humans.
Gregg, R. E., Zech, L. A., Schaefer, E. J., Stark, D., Wilson, D., & Brewer, H. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112645 · Cited by 345
Apolipoprotein E polymorphism and coronary artery disease.
Menzel, H. J., Kladetzky, R. G., & Assmann, G. (1983) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.3.4.310 · Cited by 344
(1981) · PubMed · Cited by 341
Wilson, P. W., Garrison, R. J., Castelli, W. P., Feinleib, M., McNamara, P. M., & Kannel, W. B. (1980) · The American Journal of Cardiology · doi:10.1016/0002-9149(80)90516-0 · Cited by 315
Particulate Fat in Lymph and Blood
Dole, V. P., & Hamlin, J. T. (1962) · Physiological Reviews · doi:10.1152/physrev.1962.42.4.674 · Cited by 313
Shore, V. G., & Shore, B. (1973) · Biochemistry · doi:10.1021/bi00727a022 · Cited by 281
The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.
Innerarity, T. L., Friedlander, E. J., Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44180-9 · Cited by 276
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112926 · Cited by 261
Self-citationGreen, P. H. R., Glickman, R. M., Saudek, C. D., Blum, C. B., & Tall, A. R. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109444 · Cited by 250
Polymorphism at the Apoprotein‐E locus in relation to risk of coronary disease
Cumming, A. M., & Robertson, F. W. (1984) · Clinical Genetics · doi:10.1111/j.1399-0004.1984.tb01995.x · Cited by 250
Apolipoprotein E phenotypes and hyperlipidemia
Utermann, G., Kindermann, I., Kaffarnik, H., & Steinmetz, A. (1984) · Human Genetics · doi:10.1007/bf00286508 · Cited by 239
Imaizumi, K., Fainaru, M., & Havel, R. J. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41271-4 · Cited by 224
The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding.
Weisgraber, K. H., Innerarity, T. L., Harder, K. J., Mahley, R. W., Milne, R. W., Marcel, Y. L., & Sparrow, J. T. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44181-0 · Cited by 220
Chylomicron clearance in normal and hyperlipidemic man
Grundy, S. M., & Mok, H. Y. I. (1976) · Metabolism · doi:10.1016/s0026-0495(76)80006-6 · Cited by 218
Weisgraber, K. H., & Mahley, R. W. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34612-4 · Cited by 212
Blomhoff, R., Rasmussen, M., Nilsson, A., Norum, K. R., Berg, T., Blaner, W. S., Kato, M., Mertz, J. R., Goodman, D. S., & Eriksson, U. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38759-8 · Cited by 211
Utermann, G., Pruin, N., & Steinmetz, A. (1979) · Clinical Genetics · doi:10.1111/j.1399-0004.1979.tb02028.x · Cited by 209
Havel, R. J., Kotite, L., Vigne, J. L., Kane, J. P., Tun, P., Phillips, N., & Chen, G. C. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109988 · Cited by 184
Innerarity, T. L., Weisgraber, K. H., Arnold, K. S., Rall, S. C., & Mahley, R. W. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39866-6 · Cited by 179
Radioimmunoassay studies of human apolipoprotein E.
Blum, C. B., Aron, L., & Sciacca, R. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109975 · Cited by 176
Hazzard, W. R., & Bierman, E. L. (1976) · Metabolism · doi:10.1016/0026-0495(76)90149-9 · Cited by 169
Fainaru, M., Mahley, R. W., Hamilton, R. L., & Innerarity, T. L. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38102-5 · Cited by 156
Dynamics of apolipoprotein E metabolism in humans
Blum, C. B. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38036-6 · Cited by 136
Kinetics of chylomicron remnant clearance in normal and in hyperlipoproteinemic subjects.
Cortner, J. A., Coates, P. M., Le, N., Cryer, D. R., Ragni, M. C., Faulkner, A., & Langer, T. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38721-6 · Cited by 135
Apolipoprotein E polymorphism and hyperlipidemia.
Assmann, G., Schmitz, G., Menzel, H. J., & Schulte, H. (1984) · Clinical Chemistry · doi:10.1093/clinchem/30.5.641 · Cited by 135
Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects.
Berr, F., & Kern, F. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37744-0 · Cited by 132
DeRuyter, M. G., & Leenheer, A. P. D. (1978) · Clinical Chemistry · doi:10.1093/clinchem/24.11.1920 · Cited by 106
Rw, M., & Angelin, B. (1984) · PubMed · Cited by 94
Genetic variation in human apolipoprotein E
Wardell, M. R., Suckling, P. A., & Janus, E. D. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38055-x · Cited by 89
Effects of apoprotein E polymorphism on serum lipoprotein concentration.
Robertson, F. W., & Cumming, A. (1985) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.5.3.283 · Cited by 82
Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women.
Berr, F., Eckel, R. H., & Kern, F. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38811-8 · Cited by 70
Wilson, D. E., Chan, I.-F., & Ball, M. (1983) · Metabolism · doi:10.1016/0026-0495(83)90016-1 · Cited by 67
Postchallenge plasma lipoprotein retinoids: Chylomicron remnants in endogenous hypertriglyceridemia
Wilson, D. E., Chan, I.-F., Buchi, K. N., & Horton, S. C. (1985) · Metabolism · doi:10.1016/0026-0495(85)90193-3 · Cited by 54
Berr, F., Eckel, R. H., & Kern, F. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34315-7 · Cited by 51
Schmitz, G., Assmann, G., Augustin, J., Dirkes-Kersting, A., Brennhausen, B., & Karoff, C. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34374-1 · Cited by 23
Cited by
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Apolipoprotein E: Far More Than a Lipid Transport Protein
Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
Patsch, J. R., Miesenböck, G., Hopferwieser, T., Mühlberger, V, Knapp, E., Dunn, J. K., Gotto, A. M., & Patsch, W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1336 · Cited by 1,122
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
Mahley, R. W. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1427-y · Cited by 837
Apolipoprotein E: Structure-Function Relationships
Weisgraber, K. H. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60642-7 · Cited by 830
Metadata
- Authors
- Weintraub, M. S., Eisenberg, S., & Breslow, J. L.
- Venue
- Journal of Clinical Investigation
- Published
- 1987-12-01
- Volume
- 80
- Issue
- 6
- Pages
- 1571-1577
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2003854546
- Cited by
- 418
- References
- 52
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.